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Abstract
Background: The analysis of tissue-specific protein interaction networks and their functional enrichment in
pathological and normal tissues provides insights on the etiology of diseases. The Pan-cancer proteomic project, in
The Cancer Genome Atlas, collects protein expressions in human cancers and it is a reference resource for the
functional study of cancers. However, established protocols to infer interaction networks from protein expressions are
still missing.
Results: We have developed a methodology called Inference Network Based on iRefIndex Analysis (INBIA) to
accurately correlate proteomic inferred relations to protein-protein interaction (PPI) networks. INBIA makes use of 14
network inference methods on protein expressions related to 16 cancer types. It uses as reference model the
iRefIndex human PPI network. Predictions are validated through non-interacting and tissue specific PPI networks
resources. The first, Negatome, takes into account likely non-interacting proteins by combining both structure
properties and literature mining. The latter, TissueNet and GIANT, report experimentally verified PPIs in more than 50
human tissues. The reliability of the proposed methodology is assessed by comparing INBIA with PERA, a tool which
infers protein interaction networks from Pathway Commons, by both functional and topological analysis.
Conclusion: Results show that INBIA is a valuable approach to predict proteomic interactions in pathological
conditions starting from the current knowledge of human protein interactions.
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Background
The understanding of the cell behavior and the character-
ization of the human tissues relies on both experimental
and advanced information technologies. The release of
The Cancer Proteome Atlas (TCPA) has provided pro-
teomic expression data for 190 proteins in 16 cancer types
using reverse-phase protein arrays (RPPA) technology [1].
This technique is able to measure hundreds of protein
expression levels in many cancer tissues and makes possi-
ble the study of their differences and commonalities.
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TCPA dataset contains phosphoproteins which pro-
vides information about the role of post-translational
modifications (PTMs) such as phosphorylation in cancer.
Other common PTMs include methylation and ubiqui-
tination [2]. In general, these modifications affect the
cellular processes by regulating protein-protein inter-
actions (PPIs) being a remarkable key component in
cell signaling, especially when dealing with cancer
cells [3].
Extracting valuable information from proteomic data
relies on the prediction and the analysis of their inter-
actions. In this direction, network inference methods
are widely used mainly on gene expression data. In
[4], authors have gone beyond by proposing protein
interactions inference, on 11 human cancers. For this
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purpose they used as reference model for existing inter-
actions curated biochemical pathways stored in Path-
way Commons [5]. However, pathways mostly do not
contain direct protein interactions. Therefore authors
infer such interactions by using Prior Extraction and
Reduction Algorithm by specifying the distance of the
shortest path that has to exist between two proteins
within a pathway in order to consider those two pro-
teins as interacting. Reference models are usually referred
as gold standards. In this paper we propose a method
called Inference Network Based on iRefIndex Analysis
(INBIA), to infer protein-protein interaction networks
from proteomic data, that attempts to overcome some
of the limitations reported in [4]. More precisely, we
overtake the bias in the knowledge base and the lack
of context information for PPIs by considering iRe-
fIndex [6] as gold standard for PPI networks infer-
ence [7]. iRefIndex is a consolidated database, which
accurately integrates non-redundant PPIs from several
sources by taking into account protein sequences and
taxonomy [6]. We used 16 tissues data from TCPA
and a set of 14 inference methods based on correla-
tion, partial correlation, mutual information, and regres-
sion. The statistical correlation between protein expres-
sions has important biological pros and cons because
it may entail direct or indirect interactions [7], where
the latter represents paths of pairwise directly connected
proteins. Direct and indirect interactions may repre-
sent models of signal transduction, innate and adaptive
immune signaling, cell cycle, metabolism, and DNA repair
process.
We evaluated INBIA by comparing it with the method
presented in [4], called PERA, in terms of true positive
and true negative rates of inferred interactions consider-
ing both direct and indirect interactions. For each can-
cer type, we established the best performing methods.
Moreover, we constructed predicted networks by assem-
bling the most accurate results and associating consensus
weights to interactions.
We evaluated the accuracy of predicted networks by
annotating them in Negatome [8], and by comparing
them with the tissue-specific PPI networks retrieved from
TissueNet [9] and GIANT [10]. We also provide the
functional and topological analyses of these networks,
by reporting the different patterns of mutated genes
and characterizing their diversities. Analyses showed that
INBIA is a valuable resource to predict proteomic inter-
actions in new pathological conditions starting from the
current knowledge of human protein interactions.
Methods
Datasets
We downloaded data from TCPA [11] containing RPPA
expressions of 190 proteins and phosphoproteins over
16 different cancer types (See Additional file 1: Table
S1). The RPPA technology is similar to microarray for
gene expression meaning that it can measure many pro-
teins at the same time, but conversely it is based on
specific and high-quality antibodies. Each cancer-related
dataset has a different number of samples. Datasets are
normalized by applying loading control for most of the
tissues, whereas replicates based normalization is applied
for BRCA, SKCM and THCA[1]. The normalization in
RPPA dataset is needed because, like the western blot
technique, each sample has different features such as
cell number and membrane transfer efficiency. The load-
ing control is a biological normalization procedure that
relies on the quantification through specific antibody
of another protein in order to compare their relative
amount[12, 13].
The prediction of true interactions largely depends on
the chosen gold standard. We use iRefIndex [6] as com-
prehensive and non redundant resource.
It includes 673,100 interactions covering proteins
belonging to human and other species. Among these PPIs,
we selected those having HGNC approved gene nomen-
clature. We mapped each protein to the corresponding
gene symbol removing redundant interactions. Finally, we
obtained a network with 179,387 interactions and 15,498
gene symbols. Then, we extracted the induced iRefIndex
network by TCPA gene set such that each node in the net-
work is a gene symbol within TCPA gene set. In the rest
of the paper, we simply name it as iRefIndex network or
gold standard. INBIA gold standard contains 148 nodes
and 972 edges.
Inference network based on iRefIndex analysis-INBIA
pipeline
INBIA relies on the selection of a subset of best per-
forming methods made through comparisons with the
gold standard. Figure 1 depicts INBIA methodology
to infer protein network interactions from TCPA pro-
teomic expressions for 16 cancers tissues (details on data
are reported in Results and discussion Section). INBIA
applies the 14 methods (See Fig. 1(a) and Additional file 1:
Table S2), using their default parameters.
Following the Dialogue on Reverse Engineering Assess-
ment and Methods (DREAM) Challenge for gene reg-
ulatory network inference [14], we classified the meth-
ods into four main classes: correlation/partial correlation,
linear regression and mutual information[7] (Table 1).
Results have been then filtered according to the signifi-
cance of the method’s predictions. In particular, for each
predicted protein-protein edge a p-value, based onGraph-
ical GaussianModel [15], is computed. For methods based
on mutual information we applied their own criterion to
filter false positive interactions and maintained only those
with scores greater than 0. For all the remaining methods,
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Fig. 1 Inference Network Based on iRefIndex Analysis (INBIA) pipeline. We selected 14 inference methods and applied them to the 16 RPPA datasets
in order to achieve PPI predictions (a). Networks are inferred following two approaches: (i) the predictions have been compared with the gold
standard, iRefIndex, in order to obtain true positive (TP), false positive (FP), true negative (TN) and false negative (FN) values from which it was
computed F-measure, a weighted combination of precision and recall (b). The best method for each cancer type was selected and its associated
network was returned (c); (ii) for each cancer type, an ensemble network was created by computing all possible PPIs generated from genes
associated to TCPA proteins and then a score from the ensemble of best methods (BM) that represents the percentage of BMs within the ensemble
which have predicted that PPI (d). The methods named M1, M2, . . .M14 correspond to those reported in Additional file 1:Table S2
only predicted interactions with p-value less than 0.05
have been selected.
For each inferred network, INBIA measures the good-
ness of predictions starting from the computation of true
positive and false positive rates with respect to the gold
standard. After the execution of each inference algorithm,
INBIA collects the most significant results and measures
these values. The True Positives (TP) are all the predicted
interactions that are present in the gold standard. True
Negatives (TN) are the interactions that are not predicted
by the method and are not present in the gold standard.
False Positives (FP) are the predicted interactions that are
not present in the gold standard. Finally, False Negatives
(FN) are the edges in gold standard that are not obtained
by the method. The Precision is then defined as the ratio
of TP over the sum of TP and FP. Recall is the ratio of TP
over the sum of TP and FN. The efficiency of the methods
is established by combining precision and recall into the
F-measure:
F-measure = 2 · precision · recallprecision + recall (1)
From each inferred network, we built three more net-
works in the following way: for each pair of nodes not
connected by a direct edge, we computed indirect inter-
actions by searching for paths of length k within the gold
standard, for k = 2, 3, 4, respectively. Such interactions
are referred as indirect. From now on we will only refer to
inferred networks with direct edges (i.e., k = 1).
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Table 1 Inference methods used to retrieve predictions on PPI
from cancer tissues grouped by category
Category Method name
Correlation Spearman correlation [SPEARMAN]
Pearson correlation [PEARSON]
TOM Similarity [WGCNA]
Partial Correlation Simple partial correlation [SPC]
GeneNet shrunken [GENENET]
Graphical lasso [GLASSO]
Regression Partial least squares regression [PLS]
Ridge regression [RIDGE]
Lasso regression [LASSO]
Elastic net regression [ELASTICNET]
Mutual Information ARACNE additive [ARACNEA]
ARACNE multiplicative [ARACNEM]
Context likelihood of relatedness [CLR]
Maximum relevance minimum redundancy [MRNET]
For each cancer type, INBIA infers networks by apply-
ing the 14 methods and choosing as result the network
with higher value of F-measure (Fig. 1(b)(c)). The method
which generates such network is named ’best method’.
Once the best method has been established for each of the
16 cancer tissues, an ensemble network, for each cancer
type, is built by taking into account all networks inferred
by the best methods (Fig. 1(d)). INBIA creates complete
networks whose nodes are TCPA genes and all possible
edges among them exist. Then it assigns scores to edges,
initially set to zero. Scores represent how many meth-
ods have predicted the edges. At the end, edges with
score zero are removed from the network. Unless dif-
ferently specified, we refer as INBIA inferred networks
those obtained by the best methods and not through the
ensemble computation.
INBIA validation
Comparisonwith pathway commons PPI network
The selection of a good gold standard for human PPI
network inference affects the quality of the results. We
also created a gold standard of protein interactions net-
work from Pathway Commons v2 as presented in [4]. We
selected the ontology contained in the file Pathway Com-
mons all.BIOPAX.owl and downloaded bp_prior v2.9.1
that implements Prior Extraction and Reduction Algo-
rithm (PERA) (https://bitbucket.org/armish/bp_prior).
PERA accepts as input a list of proteins together
with their post-translational modifications status and a
file containing pathways in BioPAX format. We down-
loaded the input list provided in the supplementary
files of [4]. Such list contains only TCPA proteins
with related official gene symbols and associated PTMs.
PERA produced as output a list of direct or indirect
(with mediating proteins) PPIs found within the path-
ways relative to genes provided in input. The param-
eters -graph-limit and -site-tolerance were
set to 1 and 3, respectively, for direct interactions. Pro-
teins were converted with official gene symbols achieving
790 unique interactions (See Additional file 2). We ran
the INBIA pipeline by using as gold standard the Path-
way Commons resource as described above. We then
compared the results with the original INBIA pipeline
which uses iRefIndex. For sake of simplicity, we sim-
ply refer to the pipeline based on Pathway Commons as
PERA.
Topology-based analysis
Inferred networks were compared with online resources
in order to assess their quality in terms of corrected
tissue specific predicted interactions. Negatome 2.0 [8]
reports likely non interacting proteins based on literature
mining and protein structures from Protein Data Bank
(PDB)[16]. This dataset is useful to evaluate the number
of false positives in predicting the PPIs. Negatome dis-
tinguishes between PDB and manually derived data or
combines them in order to create a unique resource. We
chose the latest stringent solution containing 6,136 PPIs
with UniProt symbols subsequently converted in a total
of 5,386 likely non-interacting proteins with official gene
symbols.
TissueNet v.2 [9] and GIANT [10] contain functional
interaction networks for several human tissues. In partic-
ular INBIA uses TissueNet, a database of tissue specific
networks obtained from HPA protein expression (Human
Protein Atlas). GIANT is based on a Bayesian method-
ology to integrate data from genome experiments and
disease conditions. GIANT classifies, for each tissue, the
edges into four classes C1-C4. C1 contains interactions
among tissue specific genes positively co-expressed in the
tissues, C2 contains interactions among tissue specific
genes and multi-tissues genes positively co-expressed.
C3 and C4 are the negative-co-expressed counterparts
of C1 and C2, respectively. Validation was carried out
by choosing key-words such that cancer tissues matched
normal counterparts. Trustfulness on edges prediction
relies on the edges’s presence in TissueNet, in C1 and
C2 GIANT classes, and their absence in Negatome. In
order to evaluate the reliability of INBIA in predicting tis-
sue specific networks from new pathological conditions,
by using the ensemble networks and tissue specific PPI
networks from TissueNet, we computed precision-recall
(PR) curves with the R package ROCR [17]. We per-
formed a topological analysis of the INBIA and PERA
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inferred networks, by making a functional annotation of
their nodes and by looking for small network motifs in
the annotated networks. A network motif is a subgraph
of the target network which occurs more frequently than
expected with respect to a random network model [14,
18, 19]. The topological information of motifs may pro-
vide insights on the main processes involving specific
tissues and may help to identify the main active pathways.
Moreover, predicted PPIs within recurrent motifs may be
present or not across the inference methods, thus being
putative biomarkers to look at. We ran FlashMotif algo-
rithm [20] to find all possible non-induced colored motifs
of 3 and 4 nodes, where a motif represents a subgraph
in which each node is ‘colored‘ with a specific GO term.
We used BiNGO [21] to annotate nodes of INBIA and
PERA inferred networks with one ormore of the following
Gene Ontology terms: phosphorylation (GO:0016310),
cell death (GO:0008219), signaling (GO:0023052) and cell
proliferation (GO:0008283). Proteins linked to none of
the previous GO terms were annotated with the generic
‘biological process‘ GO term (GO:0007582). We decided
to focus only on non-induced motifs because the num-
ber of non-induced occurrences of a motif is less sen-
sitive to the presence of false positive interactions in
a network, so the non-induced definition is more suit-
able than the induced one for PPI networks [22]. Since a
node can be associated with two or more GO terms and
FlashMotif only works with graphs where each node is
mapped with a unique color, we therefore re-structured
the networks, before running FlashMotif. In particular, if
a node had n associated GO terms we created n copies
of the node together with n copies of its links to the
other nodes in the network. Replicating nodes and edges
is necessary to avoid loosing network information and
underestimating the number of occurrences of labeled
motifs.
Functional analysis
The functional enrichment of predicted interactions was
carried out using Molecular Signature Database v5.2
(MSigDB) for gene set enrichment analysis [23]. Overlaps
with MSigDB gene sets were computed by selecting the
top 10 with false discovery rate less than 0.05 within hall-
mark gene sets which yield precise biological functions
relationships and contain genes with similar expression
patterns.
The gene mutation analysis of interacting proteins
was performed using Catalogue Of Somatic Muta-
tions In Cancer (COSMIC) v80 [24], in particular we
used the information contained in the cancer gene
census. For each cancer type, the proteins contained
in the PPI networks were extracted and annotated
with COSMIC data considering somatic and germline
mutations.
Results and discussion
We analyzed the performance of INBIA and PERA by
measuring the biological soundness of the inferred net-
works together with their functional annotation with can-
cers. Additional file 1: Table S3, summarizes the topologi-
cal properties of the inferred networks while the measures
are reported in Additional file 3. We computed Wilcoxon
rank-sum test, using the package stats in R, in order to
verify if the networks produced by INBIA and PERA
were significantly different based on their network prop-
erties (See Additional file 1: Table S3, along with p-values
produced by the statistical test). As the p-values were
never less than 0.05, we could not rejected the hypothesis,
therefore, we concluded that networks were comparable.
Intuitively, the difference in the number of interactions is
due to the nature of the resources used by iRefIndex and
Pathway Commons and their curation. iRefIndex is made
of a large number of interactions. However, this may be a
drawback since it could increase the number of false pos-
itive in the networks inferred for each cancer type. We
will verify this aspect, i.e. the accuracy of obtained com-
putational protein interactions, by using further validation
procedures.
Table 2 reports the F-measures of the best methods
of INBIA and PERA. Additional file 1: Table S4, reports
also the F-measures for indirect interactions. From the
best methods, we computed tissue-specific precision and
recall (PR) curves by using the ensemble inference net-
works for both approaches (Fig. 2). INBIA’s ensemble
set is made by 4 methods (CLR, GLASSO, PLS, and
Table 2 Cancer types and best performing inference network
methods with maximum F-measure value
Cancer Type INBIA PERA
BLCA CLR (0.188) ELASTICNET (0.179)
BRCA GLASSO (0.186) PLS (0.179)
COAD CLR (0.182) ARACNE (0.166)
GBM PLS (0.196) PLS (0.191)
HNSC PLS (0.184) PLS (0.178)
KIRC PLS (0.210) PLS (0.180)
LGG PLS (0.193) PLS (0.194)
LUAD CLR (0.187) SPEARMAN (0.188)
LUSC CLR (0.184) SPEARMAN (0.184)
OV GLASSO (0.191) PLS (0.174)
PRAD MRNET (0.191) WGCNA (0.168)
READ MRNET (0.186) CLR (0.166)
SKCM MRNET (0.188) WGCNA (0.166)
STAD PLS (0.179) PLS (0.165)
THCA PLS (0.196) PLS (0.174)
UCEC PLS (0.189) WGCNA (0.178)
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MRNET), while PERA’s best methods are: ELASTICNET,
PLS, ARACNE, SPEARMAN, WGCNA, and CLR . Tis-
sue specific networks from TissueNet are used as gold
standards to compute PR curves. PR curves assess the
goodness of INBIA and PERA in inferring pathological
networks starting from the ensemble scores assigned to
PPIs. For all cancers, INBIA performs better than PERA
even if, for some tissues, the difference between the curves
is reduced. INBIA’s precision is constant at 0.4 on aver-
age until recall reaches 0.7, then it decreases to a value
less than 0.1 when recall is maximum. It achieves the best
results for BLCA and SKCM. This trend can be associate
to a PR curve of a good classifier meaning that the pre-
dictions of INBIA based on iRefIndex are more accurate
compared to those of PERA based on Pathway Commons.
Networks obtained from the best methods for both
PERA and INBIA were compared with two datasets in
order to assess their quality in terms of corrected pre-
dicted interactions (Table 3). We associates TCPA cancer
tissues and related genes to normal counterparts, from
online resources, by considering the incidence of each
pathology in normal tissues (See Additional file 1: Table
S5). Comparing with Negatome, we found that there was,
in all cases and for both methods, a very small set of
Fig. 2 Network prediction quality based on tissue specificity. Precision-recall curves of INBIA’s (orange line) and PERA’s performances (blue line) in
predicting tissue-specific PPIs. Each plot refers to a specific cancer type. The performances were computed by considering the ensemble scores
generated from INBIA’s and PERA’s best methods and the TissueNet counterparts as ground truth (see Additional file 1: Table S5)
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interactions in common, meaning that both methods pre-
dicted few validated false negative interactions. However,
the percentage of overlapping interactions of our method
is lower compared to that of PERA. As reported in Table 3
and Additional file 1: Table S6, compared to PERA, INBIA
predicts a larger statistically significant amount of tissue
specific protein interactions present in TissueNet (p-value
<0.001 by using T-test).
Figure 3 reports the PPI predictions present in tissue
specific networks from GIANT. INBIA and PERA main-
tain the same trend: the majority of predictions belong
to classes C1 and C2, with some exceptions that show
small amounts of PPI in C3, and C4 classes. Once again,
the amount of predictions predicted of INBIA is larger
than PERA but the differences in this case has a weak
statistical significance (p-value = 0.06 by using T-test).
Fig. 3 Comparison of predicted PPI classes in GIANT. The plots show comparison between INBIA and PERA best methods for each cancer type and
relative amount of predicted PPIs that fall within each GIANT class. PPIs in C1-C2 represent functionally related pairs in the same tissue (C1) or in
multi-tissues (C2), conversely C3-C4 are likely functionally unrelated pairs. For HNSC no overlaps were found, meaning that both methods cannot
predict the interactions provided by GIANT
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Table 3 Comparisons with Negatome and TissueNet by
considering cancer types and normal counterparts (see
Additional file 1: Table S5). The overlap is reported in percentage
with respect to the number of total unique predictions per
cancer/tissue. For each tissue, we report in the first row the
percentage of INBIA’s overlapping, while in the second PERA’s
one
Cancer type Negatome (%) TissueNet (%)
BLCA 0.745 51.565
1.463 44.390
BRCA 0.247 47.654
0.830 29.461
COAD 0.609 44.901
0.806 34.274
30.323
GBM 0 36.452
28.064
25.484
19.636
0.727 26.909
20.727
15.636
HNSC 0.699 43.706
0.820 31.967
KIRC 1.608 48.231
2.137 40.171
LGG 0.62 32.812
1.020 25.510
LUAD 0.711 46.373
2.367 41.420
LUSC 0.895 46.418
3.297 43.407
OV 0.665 25.942
1.060 22.261
PRAD 0.602 39.458
0.395 32.411
READ 1.064 43.769
1.431 38.998
SKCM 0.446 54.018
0.704 42.958
STAD 0.315 43.218
0.772 35.135
THCA 0.308 26.769
40.308
0.763 19.466
26.336
UCEC 0.615 48.615
1.463 37.073
Text highlighted in italic refers to our method (INBIA), the second one to PERA
Concerning motif analysis, FlashMotif took about 4 min-
utes to retrieve all colored motifs with 3 and 4 nodes
in all the 16 INBIA and PERA tissue-specific networks.
The algorithm found 959 colored motifs with 3 nodes
and 9,006 motifs with 4 nodes in INBIA networks. In
PERA networks, FlashMotif found 798 motifs with 3
nodes and 5,489 motifs with 4 nodes. However, very few
of them were significantly over-represented (p-value ≤
0.05). FlashMotif found just 7 over-represented motifs
with 4 nodes in the INBIA network. In PERA network,
38 motifs with 3 nodes and 903 motifs with 4 nodes were
over-represented. The higher number of over-represented
motifs found in PERA networks is mainly due to the
fact that these networks are sparser than INBIA ones.
Notwithstanding, interestingly, all 7 over-represented
motifs with 4 nodes found in INBIA networks are also
over-represented motifs in PERA networks. Table 4 lists
these motifs and, for each motif, it reports the tissue
where the motif is over-represented, the number of occur-
rences, and relative p-values. The 7 over-represented
motifs found are examples of ‘diamonds’, which are com-
mon in signal-transduction networks, because they are
related to modifications such as phosphorylation [25].
So, motif analysis shows that protein-protein interactions
of networks inferred by INBIA are biologically signifi-
cant. We computed the predicted PPIs in common among
all inferred networks (See Additional file 1: Figure S1).
Each node size in the INBIA’s and PERA’s network cor-
responds to collective influence and nodes are colored in
red if they belong to MDS. INBIA graph has one large
connected component. The graph produced for PERA
has 5 small components. According to INBIA results we
can speculate that a core module may be preserved in
different cancers. The list of all edges found with this anal-
ysis is reported in Additional file 4. We investigated the
role of genes in the inferred networks by considering the
Oncopanel, a custom targeted next-generation sequenc-
ing assay for cancer [26].We found a coremodule contain-
ing 15 genes that overlap with OncoPanel (See Additional
file 1: Figure S2). Moreover, for each cancer type, the
best PPI inference networks related to OV, BRCA, UCEC,
STAD and KIRC achieved the highest number of genes
(33, 28, 27, 26, 24, respectively) that overlap with Onco-
Panel. The complete results are reported in Additional
file 5. Minimum dominating sets (MDS) [27] and collec-
tive influence of nodes (See Additional file 1: Section 3
for the definition) for each inferred network by INBIA
and PERA are reported in Additional file 6. INBIA unrav-
els a total of 83 PPIs that includes EIF4EBP1, AKT1,
GSK3A, RPS6, MAPK1, SRC proteins as most central
in the network based on computed collective influence
centrality measure [28]. PERA achieves 12 common PPIs
in which the main central nodes are TSC2, AKT1 and
GSK3A.
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Additional file 1: Table S7, reports the enrichment of
the genes present in the whole TCPA dataset. Figure 4
shows the enriched gene sets from MSigDB [23] for
INBIA and PERA. The analysis was carried out by
using PPIs predicted from best methods for each cancer
type, as reported in Table 2. Note that each network
does not contain all TCPA proteins, since only nodes
with predicted interactions belong to the network. The
x-axis contains the number of genes overlapping with
each gene set while the y-axis represents the enriched
gene sets. HALLMARK_PI3K_AKT_MTOR_SIGNALING
always contains the majority of genes for all tissues both
for INBIA and PERA. The latter in general predicts
less PPIs and this can be seen in the smaller number of
Fig. 4 Gene Set enrichment analysis. The plot represents the most enriched gene sets for each cancer type. For each type, the best methods
predictions based on INBIA and PERA were retrieved and the gene symbols corresponding to the predicted PPIs were enriched by using MSigDB.
The x-axis contains the hallmark gene sets for each method while y-axis reports the gene symbols k that overlaps with hallmark gene sets, reported
in the legend with different colors
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Table 4 Common over-represented motifs found in INBIA and PERA networks inferred from best methods. For each motif, the number
of occurrences and relative p-values in INBIA and PERA networks are reported (CD = Cell Death, CP = Cell Proliferation, P =
Phosphorylation, S = Signaling)
Motif Cancer type INBIA PERA
THCA 6256 (0.034) 7 (2.66E-04)
LGG 10477 (0.039) 30 (3.86E-06)
THCA 4230 (0.042) 3 (0.001)
LGG 6086 (0.047) 24 (2.60E-06)
OV 4159 (0.048) 60 (3.28E-06)
THCA 2898 (0.047) 2 (0.003051681)
THCA 7039 (0.038) 7 (1.79E-05)
overlapping genes. INBIA’s best networks produce spe-
cific gene sets, e.g. HALLMARK_MTORC1_SIGNALING,
that are not present in PERA’s results. Conversely,
HALLMARK_INFLAMMATORY_RESPONSE or
HALLMARK_TNFA_SIGNALING_VIA_NFKB are not
among gene sets enriched from INBIA.
Table 5 reports the genes inferred by INBIA and PERA
annotated in COSMIC. Once again, our method, in gen-
eral, infers more mutated genes associated with specific
cancers.
Conclusions
In this paper we aimed to understand and therefore over-
come some of the limitations affecting the performances
of network inference methods. We proposed a method-
ology for protein-protein interaction network prediction
from proteomic data, called Inference Network Based on
iRefIndex Analysis (INBIA). INBIA consists of several
inference methods based on correlation, partial correla-
tion, mutual information and regression. It uses as gold-
standard protein interaction networks (iRefIndex). The
reliability of our approach is assessed on a set of tissue-
specific PPI networks built on top of TCPA data. We
compared INBIA with PERA [4], which instead relies on
Pathway Common database as gold-standard. The results
show that our approach is capable to recover better PPI
interaction networks, in terms of precision-recall, with
respect to those retrieved by PERA when compared on
TissueNet [9]. Furthermore, a comparison of the inferred
networks using GIANT tissue/edges classification shows
that INBIA networks contain more interactions among
tissue specific genes positively co-expressed in the tissue.
Moreover, INBIA retrieves interactions involving a larger
set of known cancer mutated genes and networks con-
tain significantly expressed motifs. INBIA results show a
consistent core module of interactions preserved in dif-
ferent cancers, composed of topological significant nodes,
i.e. with high collective influence and belonging to min-
imum dominating sets. On the other hand both INBIA
and PERA return very few false positive interactions
with respect to the Negatome. Therefore, the comparison
clearly highlights that the selection of a proper reference
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Table 5 COSMIC mutation analysis by considering genes related to PPIs predicted from best methods in our and PERA approaches
and the relative amount of somatic and germline mutated genes
Cancer type Somatic mutation Germline mutation
BLCA ERBB3,NOTCH1,TSC1 –
BRCA AKT1,ARID1A,BAP1,BRCA2,CCND1,CDH1,CDKN1B,
ERBB2,ESR1,NOTCH1,PIK3CA,RB1,TP53 BRCA2,CHEK2,RB1,TP53
AKT1,BRCA2,CCND1,CDH1,CDKN1B,ERBB2,ESR1, BRCA2,CHEK2,TP53
GATA3,NOTCH1,PIK3CA,TP53
COAD ERBB3 –
GBM PIK3CA,PIK3R1 –
HNSC ERBB3,MTOR,NOTCH1,TSC2 –
KIRC MET,MTOR,NF2,TSC1,TSC2,VHL MET,TSC1,TSC2,VHL
MET,MTOR,TSC1,TSC2,VHL
LGG BRAF,EGFR,PTEN,RAF1,TP53 ATM,PTEN,TP53
LUAD NOTCH1,RB1,TP53 RB1
– –
LUSC NOTCH1,RB1,TP53 RB1
TP53 –
OV AKT1,ARID1A,BRAF,BRCA2,CCNE1,CTNNB1,ERBB2, BRCA2,MSH2,MSH6,STK11
MAPK1,MSH2,PIK3R1
AKT1,BRAF,CCNE1,CTNNB1,ERBB2,MAPK1,PIK3R1 –
PRAD AR,BRAF,NDRG1,PTEN,RAF1 PTEN
AR,BRAF,RAF1 –
READ AKT1,BRAF,CTNNB1,MAP2K1,MSH2,MSH6,PIK3CA, MSH2,MSH6
PIK3R1,SMAD3,SMAD4,SRC,TP53
AKT1,BRAF,CTNNB1,MAP2K1,PIK3CA,PIK3R1,SMAD3,SMAD4,SRC,TP53 –
SKCM ERBB3,NOTCH1 –
STAD BRAF,CDH1,ERBB2,ERBB3,PIK3CA CDH1
THCA BRAF,MTOR CDKN1B
BRAF,NRAS
UCEC MSH2,MTOR,PTEN,SRC MSH2,MSH6,PTEN
MTOR,PTEN,SRC,YWHAE PTEN
For each cancer type, tuple highlighted in italic refers to our method (INBIA), the second one to PERA. When only one record per cancer type is present then it means that the
two approaches achieved the same results
database is crucial to establish the actual soundness of
inference network models.
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